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that normally crowd the AIS’s plasma membrane dispersed. When ankyrinG was absent the erstwhile 
axons began to resemble dendrites, sprouting spines and developing excitatory synapses. Characteristic 
molecules from the cell body and dendrites, such as the microtubule polymerizing protein MAP2, also 
infi  ltrated the axons.
The AIS appears to serve as a fi  lter that screens out dendritic proteins, Hedstrom et al. conclude. 
How the structure bars some proteins from the axon is still uncertain. Injuries and diseases can 
transform dendrites into axons. The fi  ndings raise the possibility that these insults could cause the 
reverse transformation by changing the amount of ankyrinG and altering the AIS.
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<addart type=”rel” doi=”10.1083/jcb.200804041”>Aucott et al. </addart> report the fi  rst in vivo experiments on the heterochromatin protein 1 (HP1) family, which 
sidles up to silent DNA. The results add to the evidence that the different versions of the proteins help 
cells fi  x broken DNA.
The function of HP1 proteins has puzzled researchers. The proteins, which come in three forms 
in mammals, cozy up to heterochromatin—the tightly wound sections of DNA where genes are 
usually inactive. Early studies indicated that the proteins’ job was to turn genes off. But recent work 
suggested that the proteins are essential for repairing damaged DNA. These results came from in vitro 
studies, however, and the proteins’ powers in vivo remained uncertain.
Aucott et al.  created the fi  rst mouse strain missing one of the HP1 versions, HP1. The animals 
die shortly after birth because their lungs don’t infl  ate. The rodents show brain defects as well. 
Large numbers of neurons die, for example, and the neural stem cells in the cortex divide sluggishly. 
Both effects could arise from unfi  xed DNA. When the researchers grew brain cells from HP1-
lacking mice in culture, they saw clear indications of genomic instability that can result from faulty 
DNA repair, including unpaired sister chromatids that separated prematurely and even extra sets of 
chromosomes. The HP1 proteins latch onto the methylated version of the H3 histone, but how this 
interaction promotes repair is an unanswered question.
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A colon cancer cell isn’t a lost cause. Vitamin D can tame the rogue cell by adjusting everything from 
its gene expression to its cytoskeleton.  <addart type=”rel” doi=”10.1083/jcb.200803020”>Ordóñez-Morán et al. </addart> show that one pathway governs the 
vitamin’s diverse effects. The results help clarify the actions of a molecule that is undergoing clinical 
trials as a cancer therapy.
Vitamin D stymies colon cancer cells in two ways. It switches on genes such as the one that 
encodes E-cadherin, a component of the adherens junctions that anchor cells in epithelial layers. 
The vitamin also induces effects on the cytoskeleton that are required for gene regulation and 
short-circuiting the Wnt/-catenin pathway, which is overactive in most colon tumors. The net 
result is to curb division and prod colon cancer cells to differentiate into epithelial cells that settle 
down instead of spreading.
To delve into the mechanism, the team dosed colon cancer cells with calcitriol, the metabolically 
active version of vitamin D. Calcitriol triggered a surge of calcium into the cells and the subsequent 
switching on of RhoA–RhoGTPases, which have been implicated in the cytoskeletal changes induced 
by vitamin D. The activated RhoA in turn switched on one of its targets, the rho-associated coiled 
kinase (ROCK), which then roused two other kinases. Each step in this nongenomic pathway was 
necessary to spur the genomic responses, the researchers showed. The team also nailed down the 
contribution of the vitamin D receptor (VDR). The receptor was crucial at the beginning of the pathway, 
where it permitted the calcium infl  ux, and at the end, where it activated and repressed genes.
The study is the fi  rst to show that vitamin D’s genomic and nongenomic effects integrate to 
regulate cell physiology. One question the researchers now want to pursue is whether VDR from 
different locations—the nucleus, the cytosol, and possibly the cell membrane—has different functions 
in the pathway.
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Vitamin D spurs cancer cells to 
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